Get the latest Science News and Discoveries

FDA Approves Eli Lilly’s GLP-1 Pill

Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.

None

Related news:

Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion

FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.’s Wishes

Innovative CAR-T cell therapy receives FDA Breakthrough Therapy designation - EurekAlert!